Answers are grounded in this paper and cite their sources.
Background Bipolar disorder (BD) is frequently accompanied by substance use disorder (SUD), which may exacerbate psychotic spectrum symptoms. This study aimed to compare levels of magical ideation (MI) and perceptual aberration (PA) among patients with BD with comorbid SUD (BD+SUD), patients with BD without SUD (BD-SUD), and healthy controls (HC), and to examine substance-specific effects.Methods The sample consisted of 60 male BD+SUD patients (cannabis or methamphetamine users), 60 male BD-SUD patients, and 60 healthy male controls. The Magical Ideation Scale (MIS) and the Perceptual Aberration Scale (PAS) were administered to all participants.Results MIS and PAS scores differed significantly among groups (p < 0.001), with the highest scores observed in the BD+SUD group, followed by the BD−SUD group and HC. Within the BD+SUD group, cannabis users had higher MIS scores, whereas methamphetamine users had higher PAS scores. Duration of substance use independently predicted MIS scores, while frequency of use independently predicted PAS scores.Discussion Comorbid SUD intensifies schizotypal symptoms in BD in a substance-specific manner. Cannabis predominantly affects thought content, whereas methamphetamine primarily disrupts perceptual processes. Patients with BD and comorbid SUD constitute a high-risk group for psychotic spectrum symptoms, underscoring the importance of close clinical monitoring and targeted interventions.
No takes yet. Share an insight, caveat, or question.
Yılmaz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: